In early studies, sera from pregnant women, as well as those from patients with Sjögren syndrome or systemic lupus erythematosus (SLE), exhibited increased antibody reactivity against a peptide corresponding to a predicted epitope from the ERV3–1 envelope glycoprotein and to recombinant protein (105). This evidence concerns the gene ERVW-1 and systemic lupus erythematosus.